부산대학교 도서관

(Purpose) The major drawback of the current treatment for superficial bladder tumor is the high rate of recurrence. Especially, the tumor with grade 3 component has a tendency to recur and progress in stage. However, we have difficulty in predicting tumor recurrence and stage progression accurately by conventional clinicopathological factors. We evaluated the efficacy of p53 and Ki-67 overexpression as a predictor of recurrence or prognosis in patients with superficial bladder tumor of grade 3.(Materials and methods) Samples were obtained from 41 patients with superficial transitional cell carcinoma of the bladder of grade 3 who were treated by transurethral resection (TUR). The immunohistochemical study was performed using the antibodies against the p53 protein and Ki-67 antigen on formalin-fixed, paraffinembedded tissue specimens from initial tumors. We evaluated the correlation between these results and several clinicopathological factors.(Results) The p53 index and the Ki-67 index in pTa, pT1a and pT1b tumors were 26.4±30.1%, 28.6±30.0%, and 34.6±32.6% (p53) and 20.5±22.5%, 20.0±29.3%, and 29.2±28.4% (Ki-67). There was no significant difference between the each index and tumor stage.Eighteen cases (43.9%) had intravesical recurrence. The p53 index of the initial tumor from the tumor free cases (n=23), recurrent cases without stage progression (n=12), and stage progression cases (n=6) were 19.7±28.2%, 42.0±28.7%, and 42.5±32.0%. Between the recurrence-free cases and the recurrent cases without progression, the p53 index of the initial tumor had statistical significance (p<0.05). The Ki-67 index was shown to be the same pattern as the p53 index, but there was not statistical significance.Four of patients with stage progression had tumor progression within six months. Three of the patients with tumors with stage progression died of the cancer.In multivariate analysis, tumor multiplicity (p=0.01), BCG intravesical instillation (p=0.04), p53 index (p=0.01), and Ki-67 index (p=0.02) were the positive risk factors for tumor recurrence, but only the p53 index was the positive risk factor for prognosis fo the patients (p=0.03).(Conclusion) These results suggest that the immunohistochemical study of p53 overexpression is a useful predictor for tumor recurrence and prognosis in patients with superficial bladder tumor with grade 3.